Stay updated with breaking news from Active Surveillance. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Guillermo Lorenzo, postdoctoral researcher at the Oden Institute, recently published a paper regarding a framework to forecast the development and growth of tumors found in prostate cancer, providing personalized predictions to patients and clinicians.
Prostate cancer is an exceedingly common disease, affecting 1 in 8 men. When diagnosed early, many can live for years without symptoms. Rather than subject early-disease stage patients to the debilitating side-effects of radiation and surgery, clinic
Veracyte, Inc. , a leading cancer diagnostics company, today announced that a new study published in JCO Precision Oncology shows that, among patients undergoing Active Surveillance for prostate...
SEATTLE, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical stage biopharmaceutical company developing innovative proprietary medicines to address significant unmet needs in oncology with a focus on breast cancer, today announced that the first patient has been dosed with Atossa’s proprietary Selective Estrogen Receptor Modulator (SERM), (Z)-endoxifen, in the Re-Evaluating Conditions for Active Surveillance Suitability as Treatment: Ductal Carcinoma In Situ (R
Pork price in Bacolod City increased to P410 per kilo based on the latest monitoring of the Provincial Veterinary Office.Provincial Veterinarian Dr. Placeda Lem